Portal de Periódicos da CAPES

Artigo Produção Nacional Revisado por pares

BIBTEX RIS

Protracted Hypofractionated Radiotherapy for Graves' Ophthalmopathy: A Pilot Study of Clinical and Radiologic Response

2011; Elsevier BV; Volume: 82; Issue: 3 Linguagem: Inglês

10.1016/j.ijrobp.2010.09.015

1879-355X

Cejana Casimiro de Deus Cardoso, Adelmo José Giordani, Ângela Maria Borri Wolosker, Luís Souhami, Paulo Góis Manso, Rodrigo Souza Dias, Helena Regina Cômodo Segreto, Roberto Araújo Segreto,

Child Abuse and Related Trauma

Purpose To evaluate the clinical and radiologic response of patients with Graves’ ophthalmopathy given low-dose orbital radiotherapy (RT) with a protracted fractionation. Methods and Materials Eighteen patients (36 orbits) received orbital RT with a total dose of 10 Gy, fractionated in 1 Gy once a week over 10 weeks. Of these, 9 patients received steroid therapy as well. Patients were evaluated clinically and radiologically at 6 months after treatment. Clinical response assessment was carried out using three criteria: by physical examination, by a modified clinical activity score, and by a verbal questionnaire considering the 10 most common signs and symptoms of the disease. Radiologic response was assessed by magnetic resonance imaging. Results Improvement in ocular pain, palpebral edema, visual acuity, and ocular motility was observed in all patients. Significant decrease in symptoms such as tearing (p < 0.001) diplopia (p = 0.008), conjunctival hyperemia (p = 0.002), and ocular grittiness (p = 0.031) also occurred. Magnetic resonance imaging showed decrease in ocular muscle thickness and in the intensity of the T2 sequence signal in the majority of patients. Treatments were well tolerated, and to date no complications from treatment have been observed. There was no statistical difference in clinical and radiologic response between patients receiving RT alone and those receiving RT plus steroid therapy. Conclusion RT delivered in at a low dose and in a protracted scheme should be considered as a useful therapeutic option for patients with Graves’ ophthalmopathy. To evaluate the clinical and radiologic response of patients with Graves’ ophthalmopathy given low-dose orbital radiotherapy (RT) with a protracted fractionation. Eighteen patients (36 orbits) received orbital RT with a total dose of 10 Gy, fractionated in 1 Gy once a week over 10 weeks. Of these, 9 patients received steroid therapy as well. Patients were evaluated clinically and radiologically at 6 months after treatment. Clinical response assessment was carried out using three criteria: by physical examination, by a modified clinical activity score, and by a verbal questionnaire considering the 10 most common signs and symptoms of the disease. Radiologic response was assessed by magnetic resonance imaging. Improvement in ocular pain, palpebral edema, visual acuity, and ocular motility was observed in all patients. Significant decrease in symptoms such as tearing (p < 0.001) diplopia (p = 0.008), conjunctival hyperemia (p = 0.002), and ocular grittiness (p = 0.031) also occurred. Magnetic resonance imaging showed decrease in ocular muscle thickness and in the intensity of the T2 sequence signal in the majority of patients. Treatments were well tolerated, and to date no complications from treatment have been observed. There was no statistical difference in clinical and radiologic response between patients receiving RT alone and those receiving RT plus steroid therapy. RT delivered in at a low dose and in a protracted scheme should be considered as a useful therapeutic option for patients with Graves’ ophthalmopathy.